Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02016248 · ClinicalTrials.gov registry record · NA

SBRT Boost for Unfavorable Prostate Cancer'

A NA study of Prostate Cancer, sponsored by MemorialCare Health System.

Recruiting
Registry status
NA
Development phase
150
Enrollment target
3
Study locations

NCT02016248 is a NA study of Prostate Cancer that is actively recruiting participants, run by MemorialCare Health System. The registered enrollment target is 150 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (75% lower). The trial reports 3 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02016248, a NA study of Prostate Cancer, is actively recruiting participants, sponsored by MemorialCare Health System.

RECRUITING
Registry status
NA
Development phase
150 participants
Enrollment target
3
Study locations

Study Summary

The purpose of this study is to find out whether giving a short course of focused radiation called an SBRT "boost" is a safe and effective way to treat prostate cancer. This boost delivers a high dose of radiation to the prostate in a non-invasive way, similar to what is done with high dose rate (HDR) brachytherapy but without using needles. The study looks at how well this treatment controls the cancer, what side effects it may cause, and how it affects patients' quality of life over time.

Conditions Studied

Prostate Cancer

Interventions

  • RADIATION Stereotactic Body Radiotherapy

Study Locations (3)

California

  • Orange Coast Memorial Medical Center - Fountain Valley
  • Saddleback Memorial Medical Center - Laguna Hills
  • Long Beach Memorial Medical Center - Long Beach

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2012-06
Est. Completion 2029-06
Phase NA

Sponsor

MemorialCare Health System

21 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02016248

The ClinicalTrials.gov registry entry for NCT02016248 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (75% lower). The listed sponsor is MemorialCare Health System, which has 21 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Prostate Cancer appearing as the primary indexed condition, and to 1 intervention - of which Stereotactic Body Radiotherapy is the first listed.

NCT02016248 reports 3 study locations spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT02016248 about?

NCT02016248 is a clinical study titled "SBRT Boost for Unfavorable Prostate Cancer'". The purpose of this study is to find out whether giving a short course of focused radiation called an SBRT "boost" is a safe and effective way to treat prostate cancer. This boost delivers a high dose of radiation to the prostate in a non-invasive way, similar to what is done with high dose rate (HD...

What is the current status of trial NCT02016248?

This trial is currently recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2012-06. Estimated completion is 2029-06.

What conditions does trial NCT02016248 study?

This clinical trial studies the following conditions: Prostate Cancer.

What interventions are being tested in trial NCT02016248?

The interventions under investigation include: Stereotactic Body Radiotherapy (RADIATION).

Who is sponsoring clinical trial NCT02016248?

This trial is sponsored by MemorialCare Health System, which has 21 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02016248 being conducted?

This trial has 3 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Prostate Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Prostate Cancer

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.